Randomized controlled trial of the lipid-lowering therapy with rosuvastatin and atorvastatin for the patients with coronary artery disease treated with percutaneous coronary interventio

Not Applicable

• Conditions: coronary artery disease

• Registration Number: JPRN-UMIN000014342
• Lead Sponsor: Hirosaki University Graduate School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-07-01
• Study Completion: 2016-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Not provided

Exclusion Criteria

(1)Patients who developed acute myocardial infarction within 30days from percutaneous coronary intervention (2)Patinets who had been treated with percutaneous coronary intervention (3)Patients treated with fibrate-based medicine (4)Patients treated with hemodyalysis (5)Patients diagnosed with familial hypercholesterolemia (6)Patients who developed stroke within 3 months from percutaneous coronary intervention (7)Patients having liver damage (8)Patients having renal damage (9)Patients having high level of serum creatine phosphokinase (10)Patients treated with cyclosporin (11)Pregnant patients (12)Patients with hypothyroidism or muscular disorder (13)Drug abuse and alcoholic patients (14)Patients having carcinoma (15)Patients having severe complications (16)Patients having allergy of rosuvastatin or atorvastatin

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Major adverse cardiac events cardiovascular death non-fatal acute coronary syndrome non-fatal stroke target vascular revascularization

Secondary Outcome Measures

Name	Time	Method
admission by congestive heart failure etc.